Lipella pharmaceuticals doses first two patients in phase 2a oral lichen planus clinical trial

Top line data expected year-end 2024 pittsburgh, august 12, 2024 — lipella pharmaceuticals inc.

LIPO Ratings Summary

LIPO Quant Ranking